Koninklijke Philips NV ADR is a medical devices business based in the US. Koninklijke Philips NV ADR shares (PHG) are listed on the NYSE and all prices are listed in US Dollars. Koninklijke Philips NV ADR employs 67,035 staff and has a trailing 12-month revenue of around $17.8 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Koninklijke Philips NV ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Koninklijke Philips NV ADR stock undervalued or overvalued?
Valuing Koninklijke Philips NV ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Koninklijke Philips NV ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Koninklijke Philips NV ADR's P/E ratio
Koninklijke Philips NV ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 148x. In other words, Koninklijke Philips NV ADR shares trade at around 148x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Koninklijke Philips NV ADR's PEG ratio
Koninklijke Philips NV ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3632. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Koninklijke Philips NV ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Koninklijke Philips NV ADR's EBITDA
Koninklijke Philips NV ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.6 billion.
The EBITDA is a measure of a Koninklijke Philips NV ADR's overall financial performance and is widely used to measure a its profitability.
Koninklijke Philips NV ADR financials
Revenue TTM
$17.8 billion
Operating margin TTM
7.65%
Gross profit TTM
$7.7 billion
Return on assets TTM
2.37%
Return on equity TTM
1.54%
Profit margin
0.93%
Book value
$11.10
Market Capitalization
$26.8 billion
TTM: trailing 12 months
Koninklijke Philips NV ADR share dividends
Dividend payout ratio: 67.26% of net profits
Recently Koninklijke Philips NV ADR has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Koninklijke Philips NV ADR shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Koninklijke Philips NV ADR's case, that would currently equate to about $0.85 per share.
Koninklijke Philips NV ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Koninklijke Philips NV ADR's most recent dividend payout was on 5 June 2025. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2025 (the "ex-dividend date").
Have Koninklijke Philips NV ADR's shares ever split?
Koninklijke Philips NV ADR's shares were
split on a 4:1 basis on 17 April 2000
. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Koninklijke Philips NV ADR shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Koninklijke Philips NV ADR shares which in turn could have impacted Koninklijke Philips NV ADR's share price.
Koninklijke Philips NV ADR share price volatility
Over the last 12 months, Koninklijke Philips NV ADR's shares have ranged in value from as little as $20.6505 up to $29.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Koninklijke Philips NV ADR's is 0.907. This would suggest that Koninklijke Philips NV ADR's shares are less volatile than average (for this exchange).
Koninklijke Philips NV ADR overview
Koninklijke Philips N. V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions.
Frequently asked questions
What percentage of Koninklijke Philips NV ADR is owned by institutions? Currently 5.333% of Koninklijke Philips NV ADR shares are held by institutions.How many people work for Koninklijke Philips NV ADR? Latest data suggests 67,035 work at Koninklijke Philips NV ADR.When does the fiscal year end for Koninklijke Philips NV ADR? Koninklijke Philips NV ADR's fiscal year ends in December.Where is Koninklijke Philips NV ADR based? Koninklijke Philips NV ADR's address is: Philips Center, Amsterdam, Netherlands, 1096 BCWhat is Koninklijke Philips NV ADR's ISIN number? Koninklijke Philips NV ADR's international securities identification number is: US5004723038What is Koninklijke Philips NV ADR's CUSIP number? Koninklijke Philips NV ADR's Committee on Uniform Securities Identification Procedures number is: 718337504
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
